IFGL News 30.78 FTSE Epra/Nareit Dev Re Ex-US Ishares (IFGL)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 18, 2014 at 6:48 AM

FTSE Epra/Nareit Dev Re Ex-US Ishares (IFGL) 30.78 $IFGL

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Shares Down 10.9% Since SmarTrend's Sell Call (IFGL)
Comtex SmarTrend(R) - Tue Feb 04, 11:20AM CST
SmarTrend identified a Downtrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on December 4th, 2013 at $32.66. In approximately 2 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 10.89% as of today's recent price of $29.10.

RBS, DCE, IFGL, DOD, IGF, URZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Jul 10, 6:10AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Royal Bank of Scotland Group PLC (NYSE:RBS), Deutsche Bank Capital Funding Trust X (NYSE

CE), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL), Diamond Frank Exploration Inc (NYSE

OD), Ishares S&P Global Infrastructure Index Fund (NYSE:IGF), Uranerz Energy Corp (AMEX:URZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Real Estate Is a Bargain
Blogs @ The Motley Fool - Motley Fool - Thu Jun 27, 2:50PM CDT
A Real Estate Investment Trust (REIT) is "any corporation, trust or association that acts as an investment agent specializing in real estate and real estate mortgages" according to U.S. Federal income tax law. In layman's terms, this...

20.7% Return Seen to Date on SmarTrend iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Call (IFGL)
Comtex SmarTrend(R) - Thu May 23, 10:56AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 11 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 20.65% as of today's recent price of $34.06.

Shares of IFGL Up 29.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu May 02, 9:40AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 11 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 29.65% as of today's recent price of $36.60.

SKH, IFGL, AIA, IFSM, CLFD Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Apr 29, 5:48AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Skilled Healthcare Group Inc (NYSE:SKH), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL), ISHARES S&P ASIA 50 INDEX FUND (NYSE:AIA), Ishares Msci Eafe Value * (NASDAQ:IFSM), Clearfield Inc (NASDAQ:CLFD) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Has Returned 28.2% Since SmarTrend Recommendation (IFGL)
Comtex SmarTrend(R) - Thu Apr 25, 9:09AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 10 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 28.23% as of today's recent price of $36.20.

Uptrend Call Working As iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Stock Rises 26.0% (IFGL)
Comtex SmarTrend(R) - Wed Apr 17, 4:41PM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 10 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 25.97% as of today's recent price of $35.56.

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Up 26.3% Since SmarTrend Uptrend Call (IFGL)
Comtex SmarTrend(R) - Wed Apr 10, 11:00AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 10 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 26.26% as of today's recent price of $35.64.

WEALTHMAKERS.COM Issues Bullish Research Reports on CLNY, FMER, GSBC, HIBB, IFF, IFGL
M2 - Tue Mar 19, 10:37AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Colony Financial Inc (NYSE:CLNY), Firstmerit Corp (NASDAQ:FMER), Great Southern Bancorp Inc (NASDAQ:GSBC), Hibbett Sports Inc (NASDAQ:HIBB), International Flavors & Fragrances Inc (NYSE:IFF), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL)

WEALTHMAKERS.COM Issues Bullish Research Reports on FMCN, FNLC, HI, HOME, IFGL, MELI
M2 - Mon Mar 18, 11:18AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued new research reports today on the following stocks: Focus Media Holding Ltd (NASDAQ:FMCN), First Bancorp Inc (NASDAQ:FNLC), Highland Resources Inc (NYSE:HI), Home Federal Bancorp Inc (NASDAQ:HOME), iShares FTSE EPRA/NAREIT Global Real Estate ex-U.S. Index Fund (NASDAQ:IFGL), MercadoLibre Inc (NASDAQ:MELI)

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Shares Up 20.0% Since SmarTrend's Buy Recommendation (IFGL)
Comtex SmarTrend(R) - Mon Mar 11, 9:56AM CDT
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 9 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 20.01% as of today's recent price of $33.88.

19.2% Return Seen to Date on SmarTrend iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Call (IFGL)
Comtex SmarTrend(R) - Mon Mar 04, 9:39AM CST
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 9 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 19.23% as of today's recent price of $33.66.

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Shares Up 17.5% Since SmarTrend's Buy Recommendation (IFGL)
Comtex SmarTrend(R) - Wed Jan 23, 11:06AM CST
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 7 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 17.53% as of today's recent price of $33.18.

iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund Up 17.9% Since SmarTrend Uptrend Call (IFGL)
Comtex SmarTrend(R) - Fri Jan 11, 4:57PM CST
SmarTrend identified an Uptrend for iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund (NASDAQ:IFGL) on June 19th, 2012 at $28.23. In approximately 7 months, iShares FTSE EPRA/NAREIT Developed Real Estate ex-US Index Fund has returned 17.89% as of today's recent price of $33.28.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...